The primary challenges in today's IV Admixture operations are seriousmedication errors, high costs, turn-around time, waste, regulatory issues,lack of audit trails, motion injuries, space constraints and difficulty inmaintaining adequate and trained staff. i.v.STATION(TM) was designed toaddress these issues and overcome the fact that until now, the range ofproducts and technology available to mitigate these challenges has consistedof variations on the IV "piggyback" bag, outsourcing of IVs, and partialrobotic solutions that have seen very limited adoption and success over thepast decade. i.v.STATION(TM) represents a revolutionary approach in the questfor safe, accurate, efficient, and cost effective IV Admixtures. It offersunprecedented IV container flexibility, life-critical patient safety, androbotic precision and performance, all within a scalable and fail-safearchitecture.

"In the wake of prominent IV Solutions and Pharmacy Automation companies'[B|Braun, TOSHO, AHCSC-Olayan, & Can-Med's] due diligence and endorsement ofHealth Robotics' products, DIG started to study the market and existingtechnology in the IV sector in March 2008, with visits to multiple HealthRobotics' customers, factories, and R&D laboratories in the United States,Europe, and Asia-Pacific. I have personally witnessed how i.v.STATION(TM), at20-25% of the cost, 5-10% of the footprint, and comparable throughput ofother IV automation solutions in this space can truly expand Health Robotics'sole leadership position with CytoCare(TM) beyond Oncology and Immunologyinto assuring that virtually all dispensed IVs and Epidurals are safe,sterile, accurate, ready-to-administer, and cost effective," stated JohnBennett, MD, DIG's CEO.

i.v.STATION(TM) may be deployed in a variety of locations, includingcentral and satellite pharmacies and patient care areas, due to itsself-contained form and small "foot print". Pharmacies may, for the firsttime, choose a robotic configuration that suits their needs, rather thanbeing forced into the dated alternative of "one-size-fits-all" robots.Whether a Pharmacy chooses single or multiple i.v.STATION(TM) configurations,it will benefit from fully automated compounding while producing itspatient-specific or batch IV doses in a variety of syringe (1 to 60cc), bag(50ml to 1 liter), and vial (1 to 100ml) sizes. Furthermore, i.v.STATION(TM)supports "just-in-time IV filling", avoiding premium prices associated withspecialty & pre-filled bags and syringes and high cost closed-system-transferdevices.

Health Robotics has reached agreements for upcoming i.v.STATION(TM)installations to "go-live" and deliver non-hazardous IV doses to patients atthe University of Texas' M.D. Anderson Cancer Center (Houston), FairviewPharmacy Services & University of Minnesota Children's Hospital(Minneapolis), University of Colorado (Denver), Allegiance Health (Jackson,Michigan), Imperial College Healthcare NHS Trust (University of London, UK),King Faisal Specialist Hospital & Research Centre (Riyadh, Saudi Arabia),Kameda Medical Center (Japan), Dubai Health Authority (Dubai, UAE), AgeanUniversity Hospital (Izmir, Turkey), Tawam Hospital-a Johns Hopkins MedicineAffiliate (Abu Dhabi, UAE), Bozen Krankenhaus (Bozen, Italy) & CampusBiomedico University Hospital (Rome, Italy).

"The strategic partnership between Health Robotics and Devon is quicklypaying off as evidenced by the recent addition of several renowned Americanhospitals to other i.v.STATION(TM) Beta installations around the world. I amvery pleased with the prestige and diversity of the hospital pharmacists thathave chosen to partner with Health Robotics in North America for the purposeof validating with "live" patient IV Admixtures our new non-hazardous-IVsRobot's features, functions, and R.O.I. model. After developing the onlyexisting hazardous IV Robot [CytoCare(TM)], we have now leapfrogged thecompetition in non-hazardous IV Robotics as well. I look forward to meetingthese pharmacists at the Beta Kickoff in Orlando on December 9th, where PaoloGiribona and Gaspar DeViedma, the two architects behind i.v.STATION(TM) willkick-off the installation process. The upcoming i.v.STATION(TM) installationsin America represent a great mix of hospitals [academic and community,general and oncology, adult and pediatric] and even a centralized compoundingservice" stated Werner Rainer, Health Robotics' CEO.

This simultaneous global launch is a testament to Health Robotics defyingthe conventional wisdom that a start-up technology company in the healthcaresector cannot leave its competitors behind in less than 2 years. HealthRobotics will complete its i.v.STATION(TM) strategic partners' line-up overthe next 60 days after the conclusion of ongoing technical due diligence andfinancial negotiations with multiple healthcare companies in Europe, Asia,Oceania, and Latin America, some of which will take place during ASHP. TheBeta installations will be key in assuring that Health Robotics can deliver amature, feature-rich, flexible, and cost-effective product to the more than750 i.v.STATION(TM) purchase orders the company has registered from all overthe world.

About Health Robotics:

Health Robotics is the global leading supplier of life-criticalintra-venous medication preparation, compounding, and dispensing Robots,providing health care facilities around the world with robotic technology andsoftware automation solutions. The world-leading solutions CytoCare(TM)[hazardous IVs] and i.v.STATION(TM) [non-hazardous IVs] have and will greatlycontribute to ease global hospitals' & clinics' growing pressures to improvepatient safety through effective and efficient production of sterile,accurate, and ready-to-administer IVs, to decrease life-threateningmedication errors and contamination risks, and to work more efficiently,increase throughput, reduce waste, and contain spiraling costs.

About Devon International Group

The Devon International Group (DIG) is a multi-national group ofcompanies headquartered in King of Prussia, Pennsylvania, spanning thehealthcare, information technology, and international business industries.Its flagship companies includes Devon Health Services, a national healthcarecost management company and the largest privately held Preferred ProviderOrganization (PPO) in the Northeast U.S., Devon IT, the world's third largestmanufacturer of thin clients, Devon Medical, and Devon Robotics.

For additional information, please contact: Health Robotics Gaspar G. DeViedma USA: +1-609-980-7976 EUROPE: +39-346-963-4934 gaspar.deviedma@health-robotics.comSOURCE Health Robotics SRL